Alternative splicing - principles, functional consequences and therapeutic implications

被引:2
作者
Heyd, F. [1 ]
机构
[1] Univ Marburg, Inst Mol Biol & Tumorforsch, D-35032 Marburg, Germany
关键词
gene expression; pre-mRNA; alternative splicing; intron; exon; deep sequencing; proteome; DISEASE; RNA; CD45;
D O I
10.1055/s-0033-1349570
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Protein-coding genes in higher eukaryotes are transcribed as pre-mRNA in which the coding regions (exons) are separated by non-coding segments (introns). The exons are connected to form the mature mRNA in a process called splicing. In the case of alternative splicing an exon can be either included or skipped from the mature transcript leading to formation of several mRNAs from a single pre-mRNA. As over 90 % of all human genes are alternatively spliced, alternative splicing dramatically increases proteome diversity and fulfills important regulatory functions. This is underlined by mutations that interfere with splicing regulation and directly correlate with the formation of several diseases. Correction of these disturbed splicing processes has emerged as a promising therapeutic concept and has led to the development of several drugs that are currently being tested in clinical trials. © Georg Thieme Verlag KG Stuttgart New York ISSN 0012-0472.
引用
收藏
页码:339 / 342
页数:4
相关论文
共 50 条
[31]   Alternative splicing: Therapeutic target for vasculopathy in diabetic complications [J].
Li, Xiaoyue ;
Zhu, Dong ;
Zhao, Bingkun ;
Li, Qiang ;
Jin, Peisheng .
LIFE SCIENCES, 2025, 362
[32]   Alternative splicing and cancer metastasis: prognostic and therapeutic applications [J].
Marzese, Diego M. ;
Manughian-Peter, Ayla O. ;
Orozco, Javier I. J. ;
Hoon, Dave S. B. .
CLINICAL & EXPERIMENTAL METASTASIS, 2018, 35 (5-6) :393-402
[33]   Therapeutic Applications of Targeted Alternative Splicing to Cancer Treatment [J].
Lin, Jung-Chun .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (01)
[34]   Mechanisms of Neuronal Alternative Splicing and Strategies for Therapeutic Interventions [J].
Soto, Eduardo Javier Lopez ;
Gandal, Michael J. ;
Gonatopoulos-Pournatzis, Thomas ;
Heller, Elizabeth A. ;
Luo, Diou ;
Zheng, Sika .
JOURNAL OF NEUROSCIENCE, 2019, 39 (42) :8193-8199
[35]   The Role of Alternative Splicing in Cancer: Regulatory Mechanism, Therapeutic Strategy, and Bioinformatics Application [J].
Pan, Yao-Jie ;
Liu, Bo-wen ;
Pei, Dong-Sheng .
DNA AND CELL BIOLOGY, 2022, 41 (09) :790-809
[36]   Alternative splicing in human tumour viruses: a therapeutic target? [J].
Hernandez-Lopez, Hegel R. ;
Graham, Sheila V. .
BIOCHEMICAL JOURNAL, 2012, 445 :145-156
[37]   More than a messenger: Alternative splicing as a therapeutic target [J].
Black, A. J. ;
Gomorra, J. R. ;
Giudicea, J. .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2019, 1862 (11-12)
[38]   Aberrant expression of alternative splicing variants in multiple sclerosis - A systematic review [J].
Hecker, Michael ;
Ruege, Annelen ;
Putscher, Elena ;
Boxberger, Nina ;
Rommer, Paulus Stefan ;
Fitzner, Brit ;
Zettl, Uwe Klaus .
AUTOIMMUNITY REVIEWS, 2019, 18 (07) :721-732
[39]   Oncogenic KRAS alters splicing factor phosphorylation and alternative splicing in lung cancer [J].
Lo, April ;
McSharry, Maria ;
Berger, Alice H. .
BMC CANCER, 2022, 22 (01)
[40]   Neuron-specific alternative splicing of transcriptional machineries: Implications for neurodevelopmental disorders [J].
Porter, Robert S. ;
Jaamour, Farris ;
Iwase, Shigeki .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2018, 87 :35-45